Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on January 27, 2021, to report its financial results for the fourth quarter of 2020. The filing itself is brief and primarily serves to incorporate by reference a press release (Exhibit 99.1) that contains the detailed financial information. Investors should refer to this press release for specifics on the company's performance during the quarter.
Key Highlights
- 1Edwards Lifesciences reported its fourth quarter 2020 financial results on January 27, 2021.
- 2The 8-K filing incorporates by reference the press release detailing these results (Exhibit 99.1).
- 3Investors need to consult Exhibit 99.1 for the specific financial figures and operational commentary for Q4 2020.
- 4This filing is an informational update and does not contain new material agreements or executive changes.
- 5The information furnished under Item 2.02 is not considered 'filed' for regulatory purposes.